Compendium of HPLC Applications for Traditional Chinese Medicine and Chemical Drugs in China Pharmacopoeia

Significance of the Topic

High-performance liquid chromatography (HPLC) has been the cornerstone of analytical methods in both traditional Chinese medicine (TCM) and modern drugs since its introduction into the China Pharmacopoeia in 1985. Its high selectivity, sensitivity and reproducibility have driven widespread adoption and standardized quality control across diverse preparations.

Objectives and Overview of the Compendium

This work collects and organizes all HPLC methods published in Volume I (TCM) and Volume II (chemical drugs) of the 2005 China Pharmacopoeia. Part One details chromatographic assays for herbal and compound formulations, while Part Two presents methods for synthetic pharmaceuticals. Over 1,300 applications demonstrate the versatility of HPLC in pharmacopeial testing.

Methodology and Key Parameters

These methods predominantly employ reversed-phase chromatography with C18 and C8 stationary phases. Typical mobile phases include methanol-water or acetonitrile-water systems, often modified with phosphoric or acetic acid. Flow rates of 0.8–1.5 mL/min and UV detection at wavelengths tuned to specific analytes ensure optimal sensitivity and resolution. Sample preparation ranges from simple methanolic extractions to multi-step liquid–liquid or solid-phase cleanup for complex matrices.

Used Instrumentation

• Agilent 1200 Series binary and quaternary pumps with vacuum degasser
• Agilent 1200 Series high-performance autosampler and variable-wavelength or diode-array detectors
• ZORBAX SB-C18, XDB-C18 and XDB-C8 columns (4.6×150 mm or 4.6×250 mm, 5 µm)
• Thermostatted column compartments, ELSD and UV detection modules

Main Results and Discussion

The compendium assembles over 1366 validated HPLC assays covering more than 200 TCM formulations and hundreds of chemical drug products, including tablets, capsules, syrups and injections. Key compound classes include alkaloids (berberine, sinomenine), glycosides (paeoniflorin, ginsenosides), flavonoids (baicalin, rutin), anthraquinones (emodin) and steroids. Each method provides retention characteristics, calibration data and system suitability criteria, facilitating robust method transfer.

Benefits and Practical Applications

• Standardized, pharmacopeial-approved protocols enhance regulatory compliance and batch release testing.
• Comprehensive coverage supports QC laboratories, research institutions and industrial analysis of both TCM and synthetic drugs.
• Detailed chromatographic conditions and system suitability parameters ensure reproducibility across equipment and laboratories.

Future Trends and Opportunities

Advances in ultra-HPLC (UHPLC), green solvent technologies, tandem mass spectrometry detection (LC-MS/MS) and automated sample preparation are poised to address demands for higher throughput, lower solvent consumption and expanded analyte coverage. Data-driven chemometric approaches and multi-residue screening will further strengthen quality assurance in complex herbal matrices and trace-level drug analysis.

Conclusion

This compendium serves as an essential reference, consolidating HPLC methodologies from the 2005 China Pharmacopoeia. It underpins standardized method development, regulatory compliance and ongoing innovation in the analysis of traditional and modern medicinal products.

Reference

China Pharmacopoeia HPLC Chromatogram Compendium, 2005, People’s Medical Publishing House, Beijing, China, ISBN 7-117-07114-1.